Why the study?
RCA application rates remain low during CRRT due to citrate-specific metabolic side effects and the need for comprehensive protocols to prevent metabolic derangements.
Regional citrate anticoagulation provides effective circuit anticoagulation during CRRT without systemic bleeding risks, provided strict protocols are followed to prevent metabolic derangements.
RCA barriers in CRRT warrant protocol standardization; leaves open research on mitigating citrate metabolic effects.
Regional citrate anticoagulation (RCA) provides effective anticoagulation within the circuit through calcium chelation during CRRT applications. Although it provides an advantage to avoid the side effects of the systemic anticoagulation, RCA application rates remain low in practice due to the fact that there are some metabolic side effects specific to citrate and the need for comprehensive protocols to perform the procedure and prevent the citrate-related metabolic derangements. Acknowledgement about the basic principles of RCA, citrate metabolism and citrate-related metabolic side effects will help the clinician to manage RCA successfully as well as recognize the risky patients on time. In this review, the basic principles and metabolic side effects of RCA will be summarized to contribute to daily practice, and the possible difficulties and pitfalls about citrate implementation will be mentioned.
No takes yet. Share an insight, caveat, or question.
Nazlıhan Boyacı Dündar (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: